Cresco Labs Inc. (CRLBF)
OTCMKTS
· Delayed Price · Currency is USD
1.100
-0.050 (-4.35%)
Nov 22, 2024, 3:00 PM EST
Cresco Labs Revenue
Cresco Labs had revenue of $178.46M in the quarter ending September 30, 2024, a decrease of -4.53%. This brings the company's revenue in the last twelve months to $726.35M, down -5.28% year-over-year. In the year 2023, Cresco Labs had annual revenue of $756.06M, down -8.35%.
Revenue (ttm)
726.35M
Revenue Growth
-5.28%
P/S Ratio
n/a
Revenue / Employee
242.12K
Employees
2,760
Market Cap
375.61M
Revenue Chart
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Sandoz Group AG | 10.11B |
Telix Pharmaceuticals Limited | 430.80M |
Elekta AB (publ) | 1.69B |
Ryman Healthcare Limited | 411.39M |
Verano Holdings Corp. | 897.57M |
Vireo Growth Inc. | 98.53M |
Medexus Pharmaceuticals Inc. | 104.76M |
Cresco Labs News
- 2 days ago - 80% Leverage, 5.5x EBITDA: Is Cresco The High-Risk, High-Reward Play Investors Need? - Benzinga
- 3 days ago - Best And Worst Performing States For Cannabis Sales In 2024: YTD Winners & Losers - Benzinga
- 7 days ago - Top Marijuana Stocks to Watch for Explosive Growth Opportunities - MarijuanaStocks
- 9 days ago - Nomura Holdings Inc's Strategic Acquisition of Cresco Labs Inc Shares - GuruFocus
- 12 days ago - Top Marijuana Stocks to Watch as the Cannabis Market Faces Decline - MarijuanaStocks
- 16 days ago - Cresco Labs Inc. (CRLBF) Q3 2024 Earnings Call Transcript - Seeking Alpha
- 16 days ago - Cresco Labs reports Q3 results - Seeking Alpha
- 16 days ago - Cresco Labs Demonstrates Success of Cash Flow Focused Strategy with Third Quarter 2024 Financial Results - Business Wire